Sectors
LEXX
Lexaria Bioscience Corp.
0.57
20 x 0.55
2 x 0.58
bid
ask
+
0.02
3.30%
10:28 AM
timesize
| Ytd | -7.28% | |
| 1y | -41.02% |
0.56
day range
0.57
0.46
52 week range
1.55
| Open | 0.56 | Prev Close | 0.55 | Low | 0.56 | High | 0.57 | Mkt Cap | 11.32M |
| Vol | 9.89K | Avg Vol | 111.17K | EPS | -0.34 | P/E | -1.63 | Forward P/E | -5.64 |
| Beta | 0.34 | Short Ratio | 2.34 | Inst. Own | 6.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 0.60 | 200-d Avg | 0.78 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 1.99M | ||
| Research and Development Expense | 970.83K | ||
| Selling, General and Administrative Expense | 1.02M | ||
| Operating Income | -1.99M | ||
| Income Tax Expense | 14.00 | ||
| Net Income | -1.99M | ||
| Net Income Common Stock | -1.99M | ||
| Net Income Common Stock (USD) | -1.99M | ||
| Consolidated Income | -1.99M | ||
| Net Income to Non-Controlling Interests | -1.78K | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -1.99M | ||
| Earning Before Interest & Taxes (USD) | -1.99M | ||
| Weighted Average Shares | 24.81M | ||
| Weighted Average Shares Diluted | 24.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.48M | ||
| Cash and Equivalents (USD) | 3.48M | ||
| Investments | 142.10K | ||
| Investments Current | 142.10K | ||
| Trade and Non-Trade Receivables | 113.01K | ||
| Current Assets | 4.06M | ||
| Property, Plant & Equipment Net | 313.43K | ||
| Total Assets | 4.78M | ||
| Debt Current | 33.03K | ||
| Total Debt | 86.71K | ||
| Current Liabilities | 383.41K | ||
| Debt Non-Current | 53.68K | ||
| Total Liabilities | 437.09K | ||
| Accumulated Retained Earnings (Deficit) | -68.50M | ||
| Accumulated Other Comprehensive Income | -46.47K | ||
| Shareholders Equity | 4.74M | ||
| Shareholders Equity (USD) | 4.74M | ||
| Assets Non-Current | 716.46K | ||
| Total Debt (USD) | 86.71K | ||
| Goodwill and Intangible Assets | 339.02K | ||
| Liabilities Non-Current | 53.68K | ||
| Trade and Non-Trade Payables | 350.38K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 28.48K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.65M | ||
| Net Cash Flow from Investing | -27.09K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -837.00 | ||
| Net Cash Flow from Operations | -1.64M | ||
| Effect of Exchange Rate Changes on Cash | 8.97K | ||
| Share Based Compensation | 92.94K | ||